Kishore Sriram, MD
Child & Adolescent Psychiatry · Warsaw, INNPI 1710179908
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,479 of the $1,651 with a category attached, or 89.6%. It is spread thinly across 23 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $632 and has fallen 74.5% since, to $161 in 2025.
Across 96 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$383
- Jazz Pharmaceuticals Inc.$194
- Otsuka America Pharmaceutical, Inc.$176
- Alkermes, Inc.$158
- Johnson & Johnson$98
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$70
- plus $573 from 17 others
What the payments were for
- Food & beverage$1,47990%
- Education$17210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,651 in reported general payments places this provider in the 75th percentile of 56 child & adolescent psychiatry providers in Indiana.
See all child & adolescent psychiatry providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 41 | $133,223 |
| AustedoDeutetrabenazine | 19 | $114,995 |
| TrintellixVortioxetine Hydrobromide | 124 | $65,180 |
| Abilify MaintenaAripiprazole | 23 | $63,215 |
| Aripiprazole | 280 | $36,610 |
| FanaptIloperidone | 32 | $31,836 |
| VraylarCariprazine Hcl | 19 | $31,125 |
| RexultiBrexpiprazole | 12 | $19,351 |
| Lurasidone Hcl | 183 | $17,970 |
| Paliperidone ErPaliperidone | 68 | $17,558 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 136 | $15,190 |
| Clozapine | 78 | $9,105 |
| NamzaricMemantine Hcl/Donepezil Hcl | 13 | $8,058 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 28 | $7,258 |
| Buspirone Hcl | 629 | $6,697 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $98 | $133,22341 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $37 | $114,99519 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $176 | $82,56635 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $45 | $65,180124 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $55 | $31,83632 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 56 child & adolescent psychiatry providers in Indiana.
Other child & adolescent psychiatry in Warsaw
- Sharon CurtisDyer$102K
- Christopher McDougleIndianapolis$17K
- Ann KledzikIndianapolis$12K
- Teresita Briones RamiloIndianapolis$7K
- Mitchell GoldsteinSouth Bend$6K
- Lia KettenisBloomington$6K
- Hugh StarksIndianapolis$4K
- Daniel KinseyGoshen$3K
- Michael WellingIndianapolis$3K
- Sanjay MishraCarmel$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.